SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: DanZ who wrote (4484)5/26/2003 2:48:50 PM
From: StockDung  Read Replies (1) | Respond to of 5582
 
I am right here and none of my posts have been removed. The Truth should never be removed.

God Bless America



To: DanZ who wrote (4484)5/29/2003 4:26:09 PM
From: StockDung  Respond to of 5582
 
BBC FEATURES MTXX ANALYST news.bbc.co.uk



To: DanZ who wrote (4484)5/29/2003 5:32:44 PM
From: StockDung  Respond to of 5582
 
INTERESTING "Lavigne may own options, rights or warrants to purchase any of the securities of the Company"

Purchase MTXX Initial Coverage Research Report $30 ADD TO CART



EDGEWATER RESEARCH PARTNERS LLC
DISCLAIMER STATEMENT

The information contained in this report has been written by David Lavigne of EdgeWater Research Partners LLC ("Edgewater") and has been derived from sources considered reliable, but cannot be guaranteed by us. Edgewater and Lavigne are not aware of any material conflict of interest known at the time of the publication of this report. Financial projections and estimates herein represent our independent analysis based upon information in conjunction with the Company's publicly available financial statements. Edgewater and Lavigne may maintain positions in the securities referenced, which may change at any time without notice. Edgewater does not receive fees, warrants or any other compensation from issuers in connection with its research. It does however, encourage issuers and it representatives to subscribe to Edgewater's research, and from time to time, issuers and or their representatives may also purchase individual copies of Edgewater's research products. Edgewater and Lavigne may own options, rights or warrants to purchase any of the securities of the Company. This report is for informational purposes only and is not to be construed as specific investment advice or recommendations, nor as an offer to sell or a solicitation of an offer to buy any securities. The securities referenced are speculative in nature and may not be suitable for your specific investment objective. For specific investment advice or recommendations, please consult with your investment representative.

Issuer Purchase Disclosure

As of 05-09-03, Edgewater Research Partners LLC has received 0 annual "all services" subscriptions ($395 each) from MTXX employees and/or Directors. In addition, MTXX purchased 0 individual "MTXX Initial Coverage" research reports at $30 each.